Celtrix Pharmaceuticals Inc. of Santa Clara, Calif., has madeseveral organizational changes in its senior managment.Andreas Sommer has been promoted from vice president,research, to senior vice president, with overall responsibilityfor research, development, clinical, regulatory andmanufacturing activities. Dale Stringfellow, president, who hasprimary responsibility for the company's operations, will alsoassume the direction of all corporate partnering activities.Bruce Pharriss, Celtrix's chairman and chief executive officer, isrecuperating after having recently received treatment forcancer. He expects to return full-time to the company.

Allan Cochrane has been named vice president of sales andmarketing of the diagnostics division of MicroProbe Corp. ofBothell, Wash. Cochrane joined MicroProbe from DifcoLaboratories, where he had been vice president of sales andmarketing.

Alpha 1 Biomedicals Inc. of Bethesda, Md., has appointed FrankMamaril director of quality control. Mamaril joins Alpha 1Biomedicals from Baxter Healthcare Corp., where he wasmanager of quality control.

The new chief financial officer and vice president of financeand administration at Organogenesis Inc. is Michael Pieniazek.He had been treasurer and corporate controller at the Canton,Mass., company.

CytoTherapeutics Inc. of Providence, R.I., has hired DanielGeffken as chief financial officer. Geffken had been with thediversified holding company the Anderson Group, where heserved as vice president and chief financial officer.

Two executives at The Liposome Company Inc. of Princeton,N.J., have gotten promotions. Edward Silverman is now thesenior vice president of strategic operations and CharlesWilliams has taken on the post of vice president ofmanufacturing operations.

Repligen Corp. of Cambridge, Mass., has also promoted two ofits own to fill newly created vice presidencies. Don Stark hasbeen appointed vice president of marketing and corporatestrategy, and Timothy Morrison is the vice president of humanresources.

Arthur Coury has been named to the new position of vicepresident, materials and pharmaceutical research at Focal Inc.of Cambridge, Mass. Coury joins Focal from Medtronic Inc.,where he was director, polymer technology, of the company'sPromeon division.

Affymetrix Inc. of Palo Alto, Calif., has appointed Paul Berg andVernon Loucks Jr. to its board of directors. Nobel Prize winnerBerg is the Willson professor of biochemistry and director ofthe Beckman Center for Molecular and Genetic Medicine at theStanford University School of Medicine. Loucks is chairman andchief executive officer of Baxter International Inc. He alsoserves as director of The Dun & Bradstreet Corp., The QuakerOats Co. and Anheuser-Busch Companies Inc.

Progenitor Inc., a majority-owned subsidiary of InterneuronPharmaceuticals Inc. of Lexington, Mass., has promotedDouglass Given, executive vice president, to the additional postof chief operating officer. Also, H. Ralph Snodgrass joinsProgenitor as its executive director of experimental hematologyand immunology. Snodgrass had been an assistant professor atthe University of North Carolina, as well as a member of heLineberger Comprehensive Cancer Center and the ThurstonArthritis Research Center at UNC.

Roger Perrault has become the president of The IndustrialBiotechnology Association of Canada, located in Ottawa. Perraulthad been the president of IAF Biovac Inc., the vaccine divisionof BioChem Pharma of Laval, Quebec.

Cambridge Biotech Corp. of Worcester, Mass., announced thatRobert Kammer has joined the company as vice president ofmedical affairs. Kammer had been with Lilly ResearchLaboratories.

Balbir Bhogal, former project manager in SmithKline Beecham'sdepartment of immunology, has joined Zonagen Inc. of TheWoodlands, Texas, as director of immunology.

Cel-Sci Corp. of Alexandria, Va., has hired Matthew Haines asdirector of investor relations. Haines was an investor relationsand media relations consultant, and had also held accountmanagement positions with several New York-based financialpublic relations firms.

ProCyte Corp. of Kirkland, Wash., announced that Michael Deyhas joined the company as vice president of pharmaceuticaldevelopment. Dey came from Wyeth-Ayerst Laboratories,where he directed the research support of the company'sfemale health product, Premarin. ProCyte also promoted RonaldWarner to vice president of program management fromdirector of pharmaceutical development.

Armin Ramel has joined Scios Nova Inc. of Mountain View,Calif., as vice president of product development. Ramel hadbeen the senior director of Genentech Inc.'s process sciencesdivision.

Fred Craves is the new chairman of the board of directors ofNeoRx Corp. of Seattle. Craves, who replaces the company'soriginal chairman, Kevin Kinsella, was most recently presidentand chief executive officer of Berlex Biosciences, a whollyowned subsidiary of Schering AG.

Viral Testing Systems Corp. of Houston has named TrumanSusman president of its new Biotel Division and Kent Plunkettexecutive vice president of division operations. They both heldsimilar positions with Biotel Corp. before it was acquired byVTS.

Robert Tidwell, formerly vice president of marketing andbusiness development at Genetics Institute Inc., was namedexecutive vice president and chief operating officer of start-upbiotechnology company Boston Life Sciences Inc. of Waltham,Mass.

Sepracor Inc. of Marlborough, Mass., has hired David Barlow assenior vice president and general manager of the company'spharmaceuticals division. Barlow had been the vice presidentof worldwide marketing and business development for ArmourPharmaceutical Co., a division of Rhone-Poulenc Rorer.

(c) 1997 American Health Consultants. All rights reserved.